Likelihood of additional work-up among women undergoing routine screening mammography: The impact of age, breast density, and hormone therapy use

Preventive Medicine

Volumn 39, Issue 1, 2004, Pages 48-55

  Carney, Patricia A ^a   Kasales, Claudia J ^a   Tosteson, Anna N A ^a   Weiss, Julia E ^a   Goodrich, Martha E ^a   Poplack, Steven P ^a   Wells, Wendy S ^a   Titus Ernstoff, Linda ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Hormone therapy; Mammography; Work up

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CALCULATION; CANCER SCREENING; CANCER SURGERY; CONFIDENCE INTERVAL; CONSULTATION; FAMILY HISTORY; FEMALE; HEALTH CARE UTILIZATION; HORMONAL THERAPY; HUMAN; MAMMOGRAPHY; MEDICAL EXAMINATION; MENOPAUSE; PRIORITY JOURNAL;

BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MAMMOGRAPHY; MENOPAUSE; MIDDLE AGED; NEW HAMPSHIRE; PREVENTIVE HEALTH SERVICES;

EID: 2942711685     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2004.02.025     Document Type: Article

References (40)

1. Poplack S.P., Tosteson A.N., Grove M.R., Wells W.A., Carney P.A. Mammography in 53, 803 women from the New Hampshire mammography network. Radiology. 217:2000;832-840
2. Gajdos C., Tartter P.I., Bleiweiss I.J., Hermann G., de Csepel J., Estabrook A., et al. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Annals of Surgery. 235:2002;246-251
3. Michaelson J.S., Halpern E., Kopans D.B. Breast cancer: computer simulation method for estimating optimal intervals for screening. Radiology. 212:1999;551-560
4. Force USPST. Recommendations and Rationale: Screening for Breast Cancer, 2002. Available at http://www.ahrq.gov/clinic/3rduspstf/breastcancer/brcanrr. htm.
5. Houssami N., Irwig L., Simpson J.M., McKessar M., Blome S., Noakes J. Sydney Breast Imaging Accuracy Study: comparative sensitivity and specificity of mammography and sonography in young women with symptoms. American Journal of Roentgenology. 180:2003;935-940. [see comment]
6. Steinberg K.K., Thacker S.B., Smith S.J., Stroup D.F., Zack M.M., Flanders W.D., et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. Journal of American Medical Association. 265:1991;1985-1990. [see comment][erratum appears in JAMA 1991 Sep. 11; 266 (10) 1362]
7. Persson I., Thurfjell E., Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. Journal of Clinical Oncology. 15:1997;3201-3207
8. Knight J.A., Martin L.J., Greenberg C.V., Lockwood G.A., Byng J.W., Yaffe M.J., et al. Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiology, Biomarkers, and Prevention. 8:1999;123-128
9. Pankow J.S., Vachon C.M., Kuni C.C., King R.A., Arnett D.K., Grabrick D.M., et al. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. Journal of the National Cancer Institute. 89:1997;549-556. [see comment]
10. Wellings S.R., Wolfe J.N. Correlative studies of the histological and radiographic appearance of the breast parenchyma. Radiology. 129:1978;299-306
11. Laya M.B., Larson E.B., Taplin S.H., White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. Journal of the National Cancer Institute. 88:1996;643-649. [see comment]
12. Thurfjell E.L., Holmberg L.H., Persson I.R. Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology. 203:1997;339-341. [see comment]
13. Boyd N.F., Lockwood G.A., Byng J.W., Tritchler D.L., Yaffe M.J. Mammographic densities and breast cancer risk. Cancer Epidemiology, Biomarkers, and Prevention. 7:1998;1133-1144
14. Fisher E.R., Palekar A., Kim W.S., Redmond C. The histopathology of mammographic patterns. American Journal of Clinical Pathology. 69:1978;421-426
15. Bland K.I., Kuhns J.G., Buchanan J.B., Dwyer P.A., Heuser L.F., O'Connor C.A., et al. A clinicopathologic correlation of mammographic parenchymal patterns and associated risk factors for human mammary carcinoma. Annals of Surgery. 195:1982;582-594
16. Arthur J.E., Ellis I.O., Flowers C., Roebuck E., Elston C.W., Blamey R.W. The relationship of "high risk" mammographic patterns to histological risk factors for development of cancer in the human breast. British Journal of Radiology. 63:1990;845-849
17. Boyd N.F., Jensen H.M., Cooke G., Han H.L. Relationship between mammographic and histological risk factors for breast cancer. Journal of the National Cancer Institute. 84:1992;1170-1179
18. Lee M.M., Petrakis N.L., Wrensch M.R., King E.B., Miike R., Sickles E. Association of abnormal nipple aspirate cytology and mammographic pattern and density. Cancer Epidemiology, Biomarkers, and Prevention. 3:1994;33-36
19. Carney P.A., Miglioretti D.L., Yankaskas B.C., Kerlikowske K., Rosenberg R., Rutter C.M., et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Annals of Internal Medicine. 138:2003;168-175. [see comment][erratum appears in Ann. Intern. Med. 2003 May 6; 138 (9) 771]
20. Brett J., Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. Journal of Public Health Medicine. 23:2001;292-300
21. Lindberg N.M., Wellisch D. Anxiety and compliance among women at high risk for breast cancer. Annals of Behavioral Medicine. 23:2001;298-303
22. Drossaert C.H., Boer H., Seydel E.R. Does mammographic screening and a negative result affect attitudes towards future breast screening? Journal of Medical Screening. 8:2001;204-212
23. Carney P.A., Poplack S.P., Wells W.A., Littenberg B. The New Hampshire Mammography Network: the development and design of a population-based registry. American Journal of Roentgenology. 167:1996;367-372. [comment]
24. D'Orsi C.J.B.L., Feig S.A., Jackson V.P., Kopans D.B., Linver M.N., Sickles E.A., et al. Breast Imaging Reporting and Data System. Third ed. 1998;American College of Radiology
25. Harvey J.A. Use and cost of breast imaging for postmenopausal women undergoing hormone replacement therapy. American Journal of Roentgenology. 172:1999;1615-1619
26. Olsson J., Bengtsson B., Heijl A., Rootzen H. An improved method to estimate frequency of false positive answers in computerized perimetry. Acta Ophthalmologica Scandinavica. 75:1997;181-183
27. Gram I.T., Lund E., Slenker S.E. Quality of life following a false positive mammogram. British Journal of Cancer. 62:1990;1018-1022
28. Elmore J.G., Barton M.B., Moceri V.M., Polk S., Arena P.J., Fletcher S.W. Ten-year risk of false positive screening mammograms and clinical breast examinations. New England Journal of Medicine. 338:1998;1089-1096. [see comment]
29. Yankaskas B.C., Cleveland R.J., Schell M.J., Kozar R. Association of recall rates with sensitivity and positive predictive values of screening mammography. American Journal of Roentgenology. 177:2001;543-549
30. Coughlin S.S., Thompson T.D., Hall H.I., Logan P., Uhler R.J. Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999. Cancer. 94:2002;2801-2812
31. Smith-Bindman R., Chu P.W., Miglioretti D.L., Sickles E.A., Blanks R., Ballard-Barbash R., et al. Comparison of screening mammography in the United States and the United Kingdom. Journal of American Medical Association. 290:2003;2129-2137
32. Ballard-Barbash R., Taplin S.H., Yankaskas B.C., Ernster V.L., Rosenberg R.D., Carney P.A., et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. American Journal of Roentgenology. 169:1997;1001-1008
33. May D.S., Lee N.C., Nadel M.R., Henson R.M., Miller D.S. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. American Journal of Roentgenology. 170:1998;97-104. [see comment]
34. Bucchi L.F.F., Baraldi G.P., Bondi A., Bonsanto R., Bravetti P., Desiderio F., et al. Integrating self-referral for mammography into organised screening: results from an Italian experience. Journal of Medical Screening. 10:2003;134-138
35. Paquette D., Snider J., Bouchard F., Olivotto I., Bryant H., Decker K., et al. Performance of screening mammography in organized programs in Canada in 1996. The Database Management Subcommittee to the National Committee for the Canadian Breast Cancer Screening Initiative. Canadian Medical Association Journal. 163:2000;1133-1138. [see comment]
36. Taylor K.J., Merritt C., Piccoli C., Schmidt R., Rouse G., Fornage B., et al. Ultrasound as a complement to mammography and breast examination to characterize breast masses. Ultrasound in Medicine & Biology. 28:2002;19-26
37. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Writing Group for the Women's Health Initiative I. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. Journal of American Medical Association. 288:2002;321-333. [see comment][summary for patients in CMAJ. 2002 Aug. 20; 167 (4) 377-378; PMID: 12197697]
38. Lee-Han H., Cooke G., Boyd N.F. Quantitative evaluation of mammographic densities: a comparison of methods of assessment. European Journal of Cancer Prevention. 4:1995;285-292
39. Berg W.A., Campassi C., Langenberg P., Sexton M.J. Breast Imaging Reporting and Data System: inter- and intraobserver variability in feature analysis and final assessment. American Journal of Roentgenology. 174:2000;1769-1777
40. Jong R., Fishell E., Little L., Lockwood G., Boyd N.F. Mammographic signs of potential relevance to breast cancer risk: the agreement of radiologists' classification. European Journal of Cancer Prevention. 5:1996;281-286